163 related articles for article (PubMed ID: 22100268)
1. Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris.
Nett JH; Gomathinayagam S; Hamilton SR; Gong B; Davidson RC; Du M; Hopkins D; Mitchell T; Mallem MR; Nylen A; Shaikh SS; Sharkey N; Barnard GC; Copeland V; Liu L; Evers R; Li Y; Gray PM; Lingham RB; Visco D; Forrest G; DeMartino J; Linden T; Potgieter TI; Wildt S; Stadheim TA; d'Anjou M; Li H; Sethuraman N
J Biotechnol; 2012 Jan; 157(1):198-206. PubMed ID: 22100268
[TBL] [Abstract][Full Text] [Related]
2. The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin.
Liu L; Li H; Hamilton SR; Gomathinayagam S; Rayfield WJ; van Maanen M; Yin KC; Hong L; Prueksaritanont T
J Pharm Sci; 2012 Dec; 101(12):4414-8. PubMed ID: 22987365
[TBL] [Abstract][Full Text] [Related]
3. Design, modeling, and expression of erythropoietin cysteine analogs in Pichia pastoris: improvement of mean residence times and in vivo activities through cysteine-specific PEGylation.
Maleki A; Madadkar-Sobhani A; Roohvand F; Najafabadi AR; Shafiee A; Khanahmad H; Cohan RA; Namvar N; Tajerzadeh H
Eur J Pharm Biopharm; 2012 Apr; 80(3):499-507. PubMed ID: 22068050
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bioactivity and pharmacokinetic characteristics of PEGylated P.pastoris-expressed erythropoietin.
Maleki A; Najafabadi AR; Roohvand F; Shafiee A; Khanahmad H; Faghihi H; Hedayati MH; Tajerzadeh H
Drug Deliv; 2011 Nov; 18(8):570-7. PubMed ID: 21892875
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry.
Gong B; Burnina I; Stadheim TA; Li H
J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886
[TBL] [Abstract][Full Text] [Related]
6. Optimization of humanized IgGs in glycoengineered Pichia pastoris.
Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU
Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149
[TBL] [Abstract][Full Text] [Related]
7. Current state and perspectives on erythropoietin production.
Lee JS; Ha TK; Lee SJ; Lee GM
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1405-16. PubMed ID: 22820523
[TBL] [Abstract][Full Text] [Related]
8. PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.
Wang YJ; Hao SJ; Liu YD; Hu T; Zhang GF; Zhang X; Qi QS; Ma GH; Su ZG
J Control Release; 2010 Aug; 145(3):306-13. PubMed ID: 20427020
[TBL] [Abstract][Full Text] [Related]
9. Elimination of β-mannose glycan structures in Pichia pastoris.
Hopkins D; Gomathinayagam S; Rittenhour AM; Du M; Hoyt E; Karaveg K; Mitchell T; Nett JH; Sharkey NJ; Stadheim TA; Li H; Hamilton SR
Glycobiology; 2011 Dec; 21(12):1616-26. PubMed ID: 21840970
[TBL] [Abstract][Full Text] [Related]
10. Genetic engineering of Pichia pastoris to humanize N-glycosylation of proteins.
Bretthauer RK
Trends Biotechnol; 2003 Nov; 21(11):459-62. PubMed ID: 14573354
[TBL] [Abstract][Full Text] [Related]
11. Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production.
Ye J; Ly J; Watts K; Hsu A; Walker A; McLaughlin K; Berdichevsky M; Prinz B; Sean Kersey D; d'Anjou M; Pollard D; Potgieter T
Biotechnol Prog; 2011; 27(6):1744-50. PubMed ID: 22002933
[TBL] [Abstract][Full Text] [Related]
12. In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris.
Gomathinayagam S; Laface D; Houston-Cummings NR; Mangadu R; Moore R; Shandil I; Sharkey N; Li H; Stadheim TA; Zha D
J Biotechnol; 2015 Aug; 208():13-21. PubMed ID: 26015261
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two expression platforms in respect to protein yield and quality: Pichia pastoris versus Pichia angusta.
Mack M; Wannemacher M; Hobl B; Pietschmann P; Hock B
Protein Expr Purif; 2009 Aug; 66(2):165-71. PubMed ID: 19358890
[TBL] [Abstract][Full Text] [Related]
14. [Studies on fermentation conditions and purification of mutant human interleukin-2 expressed in Pichia pastoris].
Liu Y; Su C; Hu YH; Ouyang KQ; Cai SX
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):430-4. PubMed ID: 16108369
[TBL] [Abstract][Full Text] [Related]
15. Control of rHuEPO biological activity: the role of carbohydrate.
Elliott S; Egrie J; Browne J; Lorenzini T; Busse L; Rogers N; Ponting I
Exp Hematol; 2004 Dec; 32(12):1146-55. PubMed ID: 15588939
[TBL] [Abstract][Full Text] [Related]
16. Genome-scale metabolic model of Pichia pastoris with native and humanized glycosylation of recombinant proteins.
Irani ZA; Kerkhoven EJ; Shojaosadati SA; Nielsen J
Biotechnol Bioeng; 2016 May; 113(5):961-9. PubMed ID: 26480251
[TBL] [Abstract][Full Text] [Related]
17. Quo vadis? The challenges of recombinant protein folding and secretion in Pichia pastoris.
Puxbaum V; Mattanovich D; Gasser B
Appl Microbiol Biotechnol; 2015 Apr; 99(7):2925-38. PubMed ID: 25722021
[TBL] [Abstract][Full Text] [Related]
18. Humanization of yeast to produce complex terminally sialylated glycoproteins.
Hamilton SR; Davidson RC; Sethuraman N; Nett JH; Jiang Y; Rios S; Bobrowicz P; Stadheim TA; Li H; Choi BK; Hopkins D; Wischnewski H; Roser J; Mitchell T; Strawbridge RR; Hoopes J; Wildt S; Gerngross TU
Science; 2006 Sep; 313(5792):1441-3. PubMed ID: 16960007
[TBL] [Abstract][Full Text] [Related]
19. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization.
Sainathan SK; Tu L; Bishnupuri KS; Han M; Li A; Newberry RD; McDonald KG; Crimmins DL; Houchen C; Anant S; Dieckgraefe BK
Protein Expr Purif; 2005 Dec; 44(2):94-103. PubMed ID: 16213750
[TBL] [Abstract][Full Text] [Related]
20. Pichia surface display: display of proteins on the surface of glycoengineered Pichia pastoris strains.
Jacobs PP; Ryckaert S; Geysens S; De Vusser K; Callewaert N; Contreras R
Biotechnol Lett; 2008 Dec; 30(12):2173-81. PubMed ID: 18679585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
